29 August 2008
Molecular study of methicillin-resistant Staphylococcus aureus isolates at a neonatal high-risk unit in Merida, Venezuela
Elsa VelazcoABCDEFG, Beatriz NievesAE, Ana VindelDF, Evelyn AlviarezBF, Betty GutierrezB, Guillermo BianchiCMed Sci Monit 2008; 14(9): PI25-31 :: ID: 867945
Abstract
Background
Methicillin-resistant Staphylococcus aureus (MRSA) is a multiresistant microorganisms which holds first place in the world as a nosocomial pathogen. Special attention has therefore been directed to specific nosocomial surveillance systems and strict infection control measures for this microorganism in which the microbiological laboratory plays an important role by applying phenotypic and genotypic methods that permit establishing their epidemiological relationship especially in hospital outbreaks. In the present study the general objective was to study MRSA strains isolated from neonates with nosocomial infections and from healthcare personnel working in the Neonatal High Risk Unit (NHRU) of the Andes University Hospital Autonomous Institute (AUHAI) in Mérida, Venezuela.
Material and Method
Forty-three S. aureus isolates were analyzed by phenotypic and genotypic methods.
Results
In these strains, antibiotypes resistant to oxacillin, gentamicin, erythromycin, and tobramycin predominated (50%). The greater percentage of MRSA strains isolated from health personnel as well as two neonates were described as pulse types Ia and Ib, belonging to phage group II, containing type IV SCCmecA and resistant to macrolides and aminoglycosides and sensitive to clindamycin and trimethoprim-sulfamethoxazole.
Conclusions
This is the first reported case of SCCmecA type IV MRSA found in the NHRU of the AUHAI.
Keywords: Methicillin Resistance, Staphylococcal Infections - prevention & control, Intensive Care Units, Neonatal, Methicillin - therapeutic use, Infectious Disease Transmission, Professional-to-Patient, Infection Control - methods, Infant, Newborn, Venezuela - epidemiology, Staphylococcus aureus - metabolism, Cross Infection - microbiology, Anti-Bacterial Agents - therapeutic use
Editorial
01 January 2025 : Editorial
Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?DOI: 10.12659/MSM.947707
Med Sci Monit 2025; 31:e947707
In Press
Clinical Research
Butorphanol Tartrate Nasal Spray for Post-Cesarean Analgesia and Prolactin SecretionMed Sci Monit In Press; DOI: 10.12659/MSM.945224
Database Analysis
Role of the Carhart Effect and Outcomes from Surgery: A Retrospective Study of 532 Patients with Conductive...Med Sci Monit In Press; DOI: 10.12659/MSM.947061
Clinical Research
Factors Affecting Medication Adherence in Middle-Aged and Elderly Patients in China: A Cross-Sectional StudyMed Sci Monit In Press; DOI: 10.12659/MSM.945805
Review article
Characteristics and Associated Risk Factors of Broad Ligament Hernia: A Systematic ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.946710
Most Viewed Current Articles
17 Jan 2024 : Review article 6,963,278
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 700,194
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 23,571
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 18,228
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912